发明名称 Protein kinase C inhibitors and methods of their use
摘要 PKC inhibitors are disclosed. The PKC inhibitors are useful for treating PKC associated diseases, including certain cancers. The PKC inhibitors have improved efficacy at lower dosage amounts to achieve tumor regression, improved potency, PK profile, absorption, gastrointestinal tolerance and kinase selectivity.
申请公布号 AU2015298364(A1) 申请公布日期 2017.02.16
申请号 AU20150298364 申请日期 2015.08.05
申请人 Novartis AG 发明人 Visser, Michael Scott;Papillon, Julien;Luzzio, Michael Joseph
分类号 C07D401/14;A61K31/506;A61P31/04;C07D413/14 主分类号 C07D401/14
代理机构 代理人
主权项
地址